Maverick Capital
Maverick Capital is a $10 billion hedge fund and has long been known as one of the largest and most consistently successful hedge funds. The fund was started in 1993 by Lee S. Ainslie III, who was a protege of Julian Robertson at Tiger Management. The fund only invests in equities and maintains a balance of long and short positions. The most common valuation method Maverick uses is comparing sustainable free cash flow to enterprise value. Maverick seeks to hold stocks between 1 and 3 years.
View Older Stories View More Recent Stories
-
Bioinformatics Solutions, Inc. Chooses Science Exchange as the Primary Online Channel to Offer Protein de novo Sequencing Services to Scientists
-
Wind turbine makers and Shell lift European shares
-
University of Chicago wins 13th annual Alpha Challenge at UNC Kenan-Flagler Business School
-
Science Exchange Wins Two Gold Stevie® Awards in 2017 Stevie Awards for Women in Business
-
Science Exchange Announces Outsourced R&D Partnership with Alector
-
Elizabeth Iorns, Ph.D., CEO of Science Exchange Elected to the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT)
-
Form 13F-HR MAVERICK CAPITAL LTD For: Sep 30
-
Science Exchange Scientific Provider Elion Labs presenting New Research at the AAPS Annual Meeting: Breakthrough in Drug Product Particle Analysis Using Machine Learning
-
REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services
-
Partners Capital Focuses on 'Investing During Periods of Political Turmoil' at Second Annual Client Meeting
-
Science Exchange Announces New Director of Scientific Content, Gursatya “Guru” Singh
-
Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange, Named 2017 Scrip Award Executive of the Year Finalist
-
iSpecimen and Science Exchange Announce Technology Integration to Allow Instant Access to Human Biospecimens
-
J.P. Morgan Presents Robin Hood's Fifth Annual Investors Conference
-
MavenHill Capital Debuts with the Acquisition of Connecticut Coining
-
QB3 Signs Partnership with Science Exchange, Giving Early Stage Life Science Companies Access to More than 2,500 Qualified Scientific Service Providers
-
Science Exchange Honored by Goldman Sachs for Entrepreneurship
-
Cars Are the Most Dangerous Place for Smart Devices, New Consumer Survey Reveals
-
Science Exchange Appoints Jim Emerich as Chief Financial Officer
-
Science Exchange to Host Webinar on How to Prepare for EU General Data Protection Regulation (GDPR)
-
Science Exchange Survey Reveals Pain Points of Outsourcing R&D Services from Biotech and Pharma Leaders
-
Robin Hood Announces Speaker Lineup for its Investors Conference, presented by J.P. Morgan
-
Science Exchange Releases Latest Version of Enterprise Dynamic Report Tool
-
Science Exchange Signs on as LabCentral Sponsor to Support Life Science and Biotech Startups with Outsourced R&D Services
-
Artemis Health Secures $16 Million Series B Round to Equip Employers with Actionable Employment Benefits Data
-
Maverick Capital's 13F Shows New Stakes in Dow (DOW), MGM (MGM), Molson (TAP) (more...)
-
Form 13F-HR MAVERICK CAPITAL LTD For: Jun 30
-
Regalii Launches "Center" to Help Financial Institutions Become Nucleus of Consumers' Financial Lives
-
Science Exchange First & Only R&D Outsourcing Platform to Receive EU-U.S. Privacy Shield Framework Certification
-
Form 4 CASTLIGHT HEALTH, INC. For: Jul 12 Filed by: MAVERICK CAPITAL LTD
-
IndieBio-Backed Startups Gain Exclusive Access to Customized Science Exchange Outsourced R&D Platform, Helping to Level Playing Field with Larger Biopharma Companies
-
Outsourced R&D Leader Science Exchange Plans Continued Expansion, Raises $28 Million in Series C Funding
-
Form 4 CASTLIGHT HEALTH, INC. For: Jun 22 Filed by: MAVERICK CAPITAL LTD
-
The Alzheimer's Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research
-
Science Exchange Invited to Speak at the Novartis Institutes for Biomedical Research (NIBR) Seminar
-
Form 13F-HR MAVERICK CAPITAL LTD For: Mar 31
-
Form SC 13G/A CASTLIGHT HEALTH, INC. Filed by: MAVERICK CAPITAL LTD
-
Artemis Health Raises $8.3 Million Series A Round to Expand Benefits Optimization Platform
-
Science Exchange Invited to Speak at the 20th Annual Milken Institute Global Conference 2017
-
B. Riley Financial (RILY) Secures Rights to Manage Dialectic Capital Hedge Funds
-
B. Riley Asset Management Acquires Rights to Manage Dialectic Hedge Funds
-
Y Combinator launches Science Exchange-powered marketplace to support its companies' research and development
-
Science Exchange Named Finalist for Coveted Procurement Leaders World Procurement Awards
-
Utility-focused hedge fund Electron Capital hires Melloul from TIAA
-
Science Exchange Online Marketplace Now Offers Eurofins Services For Drug Development
-
Science Exchange Makes Notable Addition To Its Marketplace: Drug Development Services From Apollo Laboratories
-
Form SC 13G Aramark Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G/A CommScope Holding Compan Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G/A RADIAN GROUP INC Filed by: MAVERICK CAPITAL LTD
-
Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: MAVERICK CAPITAL LTD

